About Noida International University
Noida International University was established in 2010 by an Act (Act No. 27 of 2010) of the Uttar Pradesh State Legislature. The University is approved under Section 2(f) of the UGC Act 1956 and is empowered to award degrees under Section 22 of the UGC Act 1956. NIU is accredited by NAAC with an A+ grade (score 3.44, Cycle 1) and is a member of the Association of Indian Universities (AIU).
NIU is recognized by the Department of Scientific and Industrial Research (DSIR) as a Scientific and Industrial Research Organization (SIRO) and is a Host Institute recognized by MSME, Government of India. Students from more than 60 nations study across its 12 schools, spanning Engineering, Sciences, Management, Law, Medical and Social Sciences. The University also runs a 900-bedded hospital and a medical college, NIIMS.
About the School of Pharmacy
The School of Pharmacy, Noida International University (NIU) is committed to excellence in pharmaceutical education, research, innovation, and professional practice. Approved by the Pharmacy Council of India (PCI), the school offers industry-oriented academic programmes designed to prepare competent pharmacists, researchers, and healthcare professionals capable of addressing contemporary challenges in pharmaceutical sciences and global healthcare.
With a strong emphasis on experiential learning, the school integrates classroom instruction with extensive laboratory training, industrial exposure, research projects, and clinical perspectives. Students gain comprehensive knowledge across diverse domains, including pharmaceutics, pharmaceutical chemistry, pharmacology, pharmacognosy, pharmaceutical analysis, pharmacy practice, and biotechnology, supported by modern laboratories equipped with advanced instrumentation and experienced faculty members.
The school actively promotes interdisciplinary research in emerging areas such as artificial intelligence in drug discovery, computational pharmaceutics, nanotechnology, advanced drug delivery systems, precision medicine, pharmaceutical biotechnology, digital therapeutics, regulatory sciences, and sustainable pharmaceutical manufacturing. Through collaborations with pharmaceutical industries, healthcare organizations, and research institutions, students are encouraged to participate in internships, industrial visits, conferences, workshops, innovation challenges, and research publications, fostering both academic excellence and professional development.
Committed to the vision of “Transforming Healthcare through Innovation and Research,” the school nurtures ethical values, scientific inquiry, entrepreneurship, and lifelong learning. Its curriculum is aligned with evolving national and global healthcare needs, ensuring graduates are well prepared for careers in pharmaceutical industries, research and development, regulatory affairs, quality assurance, clinical research, hospital pharmacy, academia, and public health.
As part of Noida International University, a multidisciplinary institution with a vibrant international academic environment, the School of Pharmacy provides an ideal ecosystem for collaborative research and innovation. By integrating digital technologies, Industry 5.0 principles, and sustainable healthcare practices, it continues to contribute significantly to pharmaceutical education, translational research, and the advancement of global healthcare.
About the Conference
Pharmaceutical Sciences in the Digital Era: Fostering Innovation, Multidisciplinary Research and Sustainable Global Healthcare 2026 (ICPSDE-2026) is a two-day international conference organized by the School of Pharmacy, Noida International University, on 20–21 November 2026. The conference brings together researchers, academicians, healthcare professionals, pharmaceutical scientists, industry experts, regulatory authorities, and students to explore emerging technologies and innovative approaches that are transforming pharmaceutical sciences and global healthcare.
Covering a broad spectrum of contemporary research areas, including artificial intelligence, digital health, pharmaceutical biotechnology, nanotechnology, computational drug discovery, precision medicine, advanced drug delivery systems, clinical pharmacy, regulatory sciences, herbal medicines, and sustainable pharmaceutical manufacturing, the conference provides a multidisciplinary platform for the exchange of scientific knowledge and technological innovation. It aims to foster collaborative research that bridges pharmaceutical sciences with engineering, life sciences, biomedical sciences, information technology, and healthcare to address current and future global health challenges.
The conference seeks to promote research, innovation, and technological advancement across pharmaceutical sciences by encouraging collaboration among academicians, researchers, clinicians, industry professionals, policymakers, and scholars from India and abroad. It provides an opportunity to present cutting-edge research, discuss emerging trends, and share best practices that contribute to the development of safer, smarter, and more sustainable healthcare solutions. The scientific programme will feature keynote lectures, invited talks, technical sessions, poster presentations, and panel discussions led by internationally recognized experts from academia, research organizations, healthcare institutions, and the pharmaceutical industry.
Aligned with the principles of Industry 5.0, digital transformation, and the United Nations Sustainable Development Goals (SDGs), the conference emphasizes human-centric innovation, intelligent healthcare technologies, sustainable pharmaceutical development, and translational research that supports resilient healthcare systems. By fostering interdisciplinary collaboration and international partnerships, the conference aims to accelerate the adoption of digital technologies that enhance drug discovery, pharmaceutical manufacturing, healthcare delivery, and patient outcomes.
Selected full-length papers presented at the conference will be considered for publication in Scopus-indexed Taylor & Francis Conference Proceedings, subject to the publisher’s peer-review process, editorial policies, and Scopus indexing protocols.
Objectives of the Conference
The International Conference on Pharmaceutical Sciences in the Digital Era: Fostering Innovation, Multidisciplinary Research and Sustainable Global Healthcare 2026 (ICPSDE-2026) aims to:
Who Should Attend?
Academicians, Researchers, and Scientists
Undergraduate, Postgraduate, and Ph.D. Scholars
Pharmaceutical, Biotechnology, and Healthcare Professionals
Industry Experts, Innovators, and Entrepreneurs
AI, Digital Health, and Computational Science Professionals
International Delegates and Collaborators
Why Should You Attend?
Learn from renowned international speakers and industry experts.
Present your research and receive valuable expert feedback.
Network with leading academicians, researchers, and professionals.
Explore the latest innovations in pharmaceutical sciences and digital healthcare.
Foster interdisciplinary collaborations and research partnerships.
Enhance your academic profile with publication opportunities in Scopus-indexed Taylor & Francis Conference Proceedings (subject to peer review and publisher policies).
Gain insights into emerging technologies shaping the future of healthcare.
Receive a certificate of participation and expand your professional network.
Scientific Tracks
Thirteen tracks covering the frontier of pharmaceutical sciences and digital healthcare. Authors should submit to the track that best fits their work.
Pharmacology and Toxicology
Herbal Medicine and Phytochemistry
Clinical Pharmacy and Pharmacy Practice
Drug Discovery and Development
Pharmaceutical Analysis and Quality Control
Computational Drug Design and Bioinformatics
Regulatory Affairs and Quality Assurance
Nanotechnology and Advanced Therapeutics
Biomedical and Translational Research
Artificial Intelligence and Digital Health
Green Chemistry & Sustainable Chemicals
Allied Health Sciences and Clinical Diagnostics
Clinical Care and Patient Safety
Call for Papers & Submission Guidelines
Authors are invited to submit original, unpublished full papers across the conference tracks, ensuring strict adherence to the submission guidelines below. All submissions undergo a rigorous peer review.
Responsibilities of Authors
Authors must submit original, unpublished research that is not under consideration elsewhere. All data, methods, and findings should be presented accurately, ethically, and transparently, without fabrication, falsification, or inappropriate manipulation. Authors are responsible for properly acknowledging all sources and ensuring their work is free from plagiarism.
Any potential conflicts of interest must be disclosed at the time of submission. Simultaneous submission of the same manuscript to multiple conferences or journals is strictly prohibited.
Plagiarism Prevention
All submitted manuscripts will undergo plagiarism screening to ensure academic integrity. Manuscripts exceeding the permissible similarity threshold may be returned for revision or clarification. Confirmed cases of plagiarism will result in immediate rejection and may lead to further action by the Conference Organizing Committee.
Submission Requirements
- Submit original, unpublished full-length manuscripts through Microsoft CMT.
- Abstract should be 150–200 words, along with 5–6 keywords.
- A maximum of five (5) authors is permitted per manuscript.
- Manuscripts should not exceed 5 pages (including references) or 3,000 words.
- Use Times New Roman, 10-point font, and single (1.0) line spacing.
- Manuscripts must be submitted in editable Microsoft Word (.doc/.docx) format named “Full Name ICPSDE_2026”.
- Submissions must be original, properly cited, with a similarity index below 10%, and compliant with the conference AI usage policy.
- Only accepted and registered papers will be scheduled for presentation and considered for publication.
- Each accepted paper is entitled to one participation certificate. Additional individual certificates may be requested at a nominal fee.
- Authors must disclose any conflicts of interest during submission.
- Research involving human participants or experimental animals must have prior approval from the appropriate Institutional Ethics Committee (IEC) or Institutional Animal Ethics Committee (IAEC), where applicable.
- Authors should prepare manuscripts using the official Taylor & Francis Conference Paper Template, available on the conference website.
| Formatting at a Glance | |
|---|---|
| Paper Type | Full-Length Research Paper |
| Submission Portal | Microsoft CMT |
| File Format | Microsoft Word (.doc/.docx) |
| Abstract | 150–200 words |
| Keywords | 5–6 |
| Maximum Authors | Up to 5 |
| Manuscript Length | Max 5 pages (incl. references) or 3,000 words |
| Font | Times New Roman, 10 pt |
| Line Spacing | Single (1.0) |
| Review Process | Peer Review |
| Similarity Index | Below 10% |
| AI Usage | Only per the Conference AI Policy; authors remain responsible for originality and integrity |
| Ethical Approval | IEC/IAEC approval required for studies involving humans or animals, where applicable |
| Conflicts of Interest | Mandatory disclosure during submission |
| Publication | Scopus-indexed Taylor & Francis Conference Proceedings (subject to peer review, editorial policies, and indexing criteria) |
| Certificate | One per accepted paper; additional on request |
Submission Process
- Authors are required to submit their full-length manuscripts.
- Authors must complete the conference registration through the official registration portal within the stipulated deadline.
- Participants who wish to attend the conference without presenting a paper may also register using the same registration portal.
- Following the conference presentation, authors are expected to revise their manuscripts by incorporating the comments and suggestions received from reviewers and session participants, wherever applicable.
- The revised camera-ready manuscripts will undergo a final editorial assessment to ensure compliance with the conference publication guidelines.
- Selected and accepted papers that successfully satisfy the peer-review process, editorial requirements, and publication quality standards will be considered for publication in the Taylor & Francis Conference Proceedings, subject to the publisher’s editorial policies and Scopus evaluation and indexing criteria.
- Authors must ensure that their submissions are original, unpublished, and free from plagiarism, and comply with the conference’s publication ethics and formatting guidelines.
- The decision of the Editorial Board and Technical Program Committee regarding paper acceptance and publication shall be final.
Publication Opportunity
Accepted and presented papers will be considered for publication in Scopus-indexed Taylor & Francis Conference Proceedings (subject to Scopus protocols and checks).
Publication Ethics & Malpractice Statement
The conference is committed to maintaining the highest standards of publication ethics in accordance with the principles of the Committee on Publication Ethics (COPE) and the publication policies of Taylor & Francis. All submitted manuscripts must be original, unpublished, and free from plagiarism. Submissions will undergo plagiarism screening and, where applicable, AI-assisted content verification before being considered for peer review. A rigorous peer-review process will be followed to ensure fairness, confidentiality, and academic integrity. Any form of research misconduct, including plagiarism, data fabrication, data falsification, duplicate submission, inappropriate authorship, or undisclosed conflicts of interest, will result in rejection of the manuscript and may lead to further action by the Conference Organizing Committee.
Responsibilities of Authors
- Submit original, unpublished research not under consideration elsewhere.
- Ensure the accuracy, integrity, and transparency of all research data and findings.
- Properly acknowledge all sources and avoid plagiarism.
- Include only eligible contributors as authors.
- Disclose any conflicts of interest and obtain required ethical approvals.
- Revise manuscripts in response to reviewers’ comments.
- Avoid data fabrication, falsification, duplicate submission, and other forms of research misconduct.
Responsibilities of Reviewers
- Evaluate manuscripts objectively based on scientific merit, originality, and relevance.
- Maintain confidentiality throughout the review process.
- Provide constructive, unbiased, and timely feedback.
- Declare any conflicts of interest and ensure impartiality.
- Identify relevant uncited literature and report ethical concerns, including plagiarism or research misconduct, to the Editorial Committee.
Registration Details
| Category | Registration (Online/Offline)Starts from 10 July 2026 | On-Spot Registration | Publication |
|---|---|---|---|
| Foreign Authors | USD 50 | USD 70 | USD 150 |
| Industry Professionals | ₹ 2,000 | ₹ 3,000 | ₹ 14,000 |
| Academicians | ₹ 1,000 | ₹ 3,000 | ₹ 12,000 |
| Research Scholars | ₹ 1,000 | ₹ 2,500 | ₹ 10,000 |
| Attendees Only (Offline) | ₹ 700 | ₹ 1,000 | — |
| Attendees Only (Online) | ₹ 500 | — | — |
Note: Registration is mandatory for accepted papers. Additional 10% discount for 3 or more papers from a single author.
Important Dates
Note: Paper submission, review management, and acceptance notifications will be handled through the official Microsoft CMT portal.
Conference Committee
To be announced. The Organising Chair, Conveners, and Organising Committee of the School of Pharmacy will be updated shortly.
Contact Us
Noida International University
Plot No. 1, Sector-17 A, Yamuna Expressway,
Gautam Budh Nagar, Uttar Pradesh 201312
Conference Enquiries: icpsde2026@niu.edu.in
Website: www.niu.edu.in